en
Scientific article
English

Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old child

Published inPediatric hematology and oncology, vol. 31, no. 2, p. 143-148
Publication date2014
Abstract

In adult therapy, arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) are recognized as active treatment of relapsed acute promyelocytic leukemia (APL). The efficacy of this combination in pediatric APL has not yet been well established. We report the case of a 6-year-old girl with relapsed APL, with a PML-RARα mutation, treated with a combination of ATO and ATRA. Over a period of 5 months, she received in total, 75 doses of intravenous ATO and 40 doses of oral ATRA. Currently, 22 months after relapse, she is still in complete remission. Here, we describe treatment of a relapsed APL in a child with limited treatment of ATO and ATRA and review the literature.

Keywords
  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Arsenicals/administration & dosage
  • Child
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute/drug therapy
  • Oxides/administration & dosage
  • Recurrence
  • Tretinoin/administration & dosage
Citation (ISO format)
ROCK, Nathalie et al. Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old child. In: Pediatric hematology and oncology, 2014, vol. 31, n° 2, p. 143–148. doi: 10.3109/08880018.2013.876470
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0888-0018
472views
0downloads

Technical informations

Creation03/24/2015 1:37:00 PM
First validation03/24/2015 1:37:00 PM
Update time03/14/2023 11:04:11 PM
Status update03/14/2023 11:04:11 PM
Last indexation01/16/2024 5:29:34 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack